Cibus, Inc.
CBUSNASDAQHealthcare● Active
$1.23
$-0.06(-4.65%)
Market Cap$55949625
P/E Ratio—
52W High$4.191
52W Low$1.09
Cibus, Inc. (CBUS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CBUS · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.33
Est. -$0.35 · +5.7%
Revenue
$0.00B
Est. $0.00B · +4.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 2-Quarter EPS Beat Streak
CBUS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$78.12
Rev. $1025.0B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$78.12
Rev. Est.$1025.0B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.24 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 14, 2026 | -$0.35 | -$0.33 | +5.7% | $0.00B | $0.00B | +4.7% |
| ▲ Q1 FY2026 | Mar 17, 2026 | -$0.43 | -$0.42 | +2.3% | $0.00B | $0.00B | -35.7% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -$0.41 | -$0.44 | -7.3% | $0.00B | $0.00B | -62.6% |
| ▲ Q3 FY2025 | Aug 14, 2025 | -$0.69 | -$0.61 | +11.6% | $0.00B | $0.00B | -38.3% |
| ▼ Q2 FY2025 | May 8, 2025 | -$0.70 | -$0.74 | -5.7% | $0.00B | $0.00B | -10.3% |
| ▼ Q1 FY2025 | Mar 20, 2025 | -$0.68 | -$0.87 | -27.9% | $0.00B | $0.00B | +7.7% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.90 | $0.06 | +106.7% | $0.00B | $0.00B | -4.7% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.24
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
-$0.33
EPS Est.
-$0.35
EPS Surpr.
+5.7%
Revenue
$0.00B
Q1 FY2026
Mar 17, 2026Beat
EPS Actual
-$0.42
EPS Est.
-$0.43
EPS Surpr.
+2.3%
Revenue
$0.00B
Q4 FY2025
Nov 13, 2025Miss
EPS Actual
-$0.44
EPS Est.
-$0.41
EPS Surpr.
-7.3%
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025Beat
EPS Actual
-$0.61
EPS Est.
-$0.69
EPS Surpr.
+11.6%
Revenue
$0.00B
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$0.74
EPS Est.
-$0.70
EPS Surpr.
-5.7%
Revenue
$0.00B
Q1 FY2025
Mar 20, 2025Miss
EPS Actual
-$0.87
EPS Est.
-$0.68
EPS Surpr.
-27.9%
Revenue
$0.00B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.06
EPS Est.
-$0.90
EPS Surpr.
+106.7%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.31 | $-0.25 | $-0.19 | 1 |
| Q3 FY2027 | $-0.29 | $-0.24 | $-0.18 | 1 |
| Q2 FY2027 | $-0.31 | $-0.25 | $-0.19 | 1 |
| Q1 FY2027 | $-0.33 | $-0.27 | $-0.20 | 1 |
| Q4 FY2026 | $-0.23 | $-0.19 | $-0.14 | 1 |
| Q3 FY2026 | $-0.26 | $-0.23 | $-0.18 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +5.7% | $1.46 | $1.41 | -3.42% |
| ▲ Q1 FY2026 | Mar 17, 2026 | +2.3% | $3.56 | $3.68 | +3.37% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -7.3% | $1.35 | $1.25 | -7.41% |
| ▲ Q3 FY2025 | Aug 14, 2025 | +11.6% | $1.42 | $1.47 | +3.52% |
| ▼ Q2 FY2025 | May 8, 2025 | -5.7% | $2.50 | $2.35 | -6.00% |
| ▼ Q1 FY2025 | Mar 20, 2025 | -27.9% | $2.37 | $2.19 | -7.59% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +106.7% | $4.61 | $4.40 | -4.56% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -40.7% | $7.73 | $7.46 | -3.49% |
Q2 FY2026-3.42%
Report Date
May 14, 2026
EPS Beat/Miss
+5.7%
Price Before
$1.46
Price After
$1.41
Q1 FY2026+3.37%
Report Date
Mar 17, 2026
EPS Beat/Miss
+2.3%
Price Before
$3.56
Price After
$3.68
Q4 FY2025-7.41%
Report Date
Nov 13, 2025
EPS Beat/Miss
-7.3%
Price Before
$1.35
Price After
$1.25
Q3 FY2025+3.52%
Report Date
Aug 14, 2025
EPS Beat/Miss
+11.6%
Price Before
$1.42
Price After
$1.47
Q2 FY2025-6.00%
Report Date
May 8, 2025
EPS Beat/Miss
-5.7%
Price Before
$2.50
Price After
$2.35
Q1 FY2025-7.59%
Report Date
Mar 20, 2025
EPS Beat/Miss
-27.9%
Price Before
$2.37
Price After
$2.19
Q4 FY2024-4.56%
Report Date
Nov 7, 2024
EPS Beat/Miss
+106.7%
Price Before
$4.61
Price After
$4.40
Q3 FY2024-3.49%
Report Date
Aug 8, 2024
EPS Beat/Miss
-40.7%
Price Before
$7.73
Price After
$7.46
Avg Beat Reaction-0.27%
Avg Miss Reaction-6.12%
Beat Rate4 / 8 quarters
Largest Move-7.59% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CBUS ends December
Cibus, Inc. (CBUS) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.33 — beating the analyst consensus of $-0.35 by +5.7%. CBUS has beaten EPS estimates for 2 consecutive quarters. The next CBUS earnings date is expected around September 1, 2026.
Each quarter, investors track CBUS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CBUS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CBUS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CBUS earnings · 5 questionsCibus, Inc.'s next earnings report is expected around September 1, 2026. CBUS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CBUS historically reports after market close (AMC).
CBUS earnings datewhen is CBUS earningsCBUS next earnings datewhen does CBUS report earningsCBUS earnings calendar
▸ Source: FMP · Cibus, Inc. SEC filings · US GAAP · Cibus, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026